The Effect of Survivorship Care Plan on the Quality of Life and Supportive Care Needs of Breast Cancer Survivors: A 12-Week Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241115063723N1

Enrollment

Registered

2025-01-31

Start date

2023-11-22

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Personal history of malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: Inter Survivorship care plan group The steps for implementing the survivorship care plan were as follows: First stage: In the first stage, after completing the info

Eligibility

Sex/Gender

Female

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Females aged 18–75 years Diagnosed with invasive breast cancer (Stage I–III) within six months to two years of enrolment Willing to be randomized Had completed treatment (surgery, chemotherapy, and/or radiation) at least six months before recruitment(except for anti-hormone therapy and targeted therapy) Could use the smartphone. Stable clinical conditions

Exclusion criteria

Exclusion criteria: Plans to move from the community during the study Cancer recurrence or metastasis Secondary cancers Cognitive impairment Low self-management ability and dependence on others in disease management

Design outcomes

Primary

Measure	Time frame
Improved physical function. Timepoint: Three months after intervention. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).;Improved mental function. Timepoint: Three months. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).;Improved role performance. Timepoint: Three months. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).;Improved social and cognitive function. Timepoint: Three months. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).;Reduced physical symptoms including fatigue and pain. Timepoint: Three months. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).	—

Measure

Time frame

Improved physical function. Timepoint: Three months after intervention. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).;Improved mental function. Timepoint: Three months. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).;Improved role performance. Timepoint: Three months. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).;Improved social and cognitive function. Timepoint: Three months. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).;Reduced physical symptoms including fatigue and pain. Timepoint: Three months. Method of measurement: The EORTC QLQ-C30, The EORTC QLQ-BR23, The Supportive Care Needs Survey-Short Form-34 (SCNS SF34).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRahimeh Khajoei

Shahid Beheshti University of Medical Sciences

rahimehkhajoei@yahoo.com+98 34 4230 9657

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026